Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Here's Why Baird Slashed PayPal's Price Target By 15%

Baird analyst Colin Sebastian lowered the price target on PayPal Holdings Inc (NASDAQ:PYPL) to $175 from $205 (51.3% upside) and kept an Outperform rating on the shares. He believed steady or even accelerating trends concerning merchant integration with digital wallets were a crucial medium and long-term positive for PayPal. However, Sebastian remained cautious near term…

Benzinga

Tesla Supplier Looks To Invest $5B On EV Batteries, Supply Chain Software

Tesla Inc (NASDAQ:TSLA) battery supplier Panasonic Corp (OTC:PCRFY) (OTC:PCRFF) looked to invest ¥600 billion ($4.9 billion) in automotive batteries, supply chain software, and other areas it considered core to its growth. Panasonic looked to invest ¥400 billion in growth segments, including electric-vehicle cells, and another 200 billion yen in hydrogen device technology over three years…

Benzinga

Executives Sell Around $42M Of 5 Stocks

Although the US economy added 431,000 payrolls in March, there were a few notable insider trades.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Read About Apple's Latest Subscription Offering As It Looks To Reduce Dependence On Devices

Apple Inc (NASDAQ:AAPL) launched Apple Business Essentials, a new program for businesses to set up, manage and install software on workers' iPhones, iPads, and Macs. The product is aimed at smaller customers, primarily those without dedicated IT departments. It comes at a monthly price of $2.99 to $24.99 per worker. The product enables…

Benzinga

What 6 Analyst Ratings Have To Say About Taysha Gene Therapies

Analysts have provided the following ratings for Taysha Gene Therapies (NASDAQ:TSHA) within the last quarter:

Benzinga

Analyst Ratings For Ncino

Over the past 3 months, 7 analysts have published their opinion on Ncino (NASDAQ:NCNO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Peering Into Upstart Holdings Inc. - Common stock's Recent Short Interest

Upstart Holdings Inc. - Common stock's (NASDAQ:UPST) short percent of float has risen 11.0% since its last report. The company recently reported that it has 10.23 million shares sold short, which is 15.54% of all regular shares that are available for trading.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Expert Ratings For Ionis Pharmaceuticals

Within the last quarter, Ionis Pharmaceuticals (NASDAQ:IONS) has observed the following analyst ratings:

Benzinga

Expert Ratings For Amylyx Pharmaceuticals

Within the last quarter, Amylyx Pharmaceuticals (NASDAQ:AMLX) has observed the following analyst ratings:

Benzinga

What 7 Analyst Ratings Have To Say About Poshmark

Poshmark (NASDAQ:POSH) has observed the following analyst ratings within the last quarter:

Benzinga

4 Penny Stocks Insiders Are Buying: Heritage Global, Palisade Bio And More

US crude oil futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment…

Benzinga

12 Information Technology Stocks Moving In Friday's Pre-Market Session

Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

10 Industrials Stocks Moving In Friday's Pre-Market Session

Benzinga

The Daily Biotech Pulse: SELLA In-licenses Oncology Asset, Merck's Pneumococcal Vaccine Review Extended, Arc Biopharma COVID Drug Flunks Mid-Stage Study

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

Yatra Online: Q3 Earnings Insights

Yatra Online (NASDAQ:YTRA) reported its Q3 earnings results on Friday, April 1, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Enveric Biosciences Reports Full-Year 2021 Financial Results

Enveric Biosciences Inc. (NASDAQ:ENVB) reported its financial results for the full year ended December 31, 2021. 2021 Financial Results Comprehensive net loss for the year was $48.8 million, including $36.3 million in net non-cash expenses, with a basic and diluted loss per share of $2.07, as compared to a…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

High Tide Buys Boreal Cannabis Co, Blessed CBD Makes UK List Of Marijuana Products Permitted To Sell

High Tide Inc. (NASDAQ:HITI) (TSXV:HITI) (FSE:2LYA) is expanding its brick-and-mortar retail cannabis operations, by entering into a definitive agreement through which High Tide will acquire 100% of the equity interest of 2080791 Alberta Ltd. operating as Boreal Cannabis Company that operates two retail cannabis stores in Alberta for CAD$2.2 million, plus the wholesale…

Benzinga

Why Alibaba, Nio And Pinduoduo Shares Are Rising Today

Shares of several Chinese stocks, including Alibaba Group Holding Ltd (NYSE: BABA), Nio Inc (NYSE: NIO) and Pinduoduo Inc (NASDAQ:

Benzinga

Could Robinhood Shares Continue To Fall?

Shares of Robinhood Markets Inc (NASDAQ: HOOD) tanked 7.21% to close Thursday’s trading at $13.51.

Benzinga

Jim Cramer Gives His Opinion On AT&T, Kosmos Energy And More

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Gevo, Inc. (NASDAQ: GEVO) should be "working better here, but it’s losing too much money."

Benzinga

CNBC's Final Trades: Carlyle Group, Oracle, Kinder Morgan And This Defensive Play

On CNBC’s “Halftime Report Final Trades,” Josh Brown of Ritholtz Wealth Management said he was long on Carlyle Group Inc (NASDAQ: CG).

Benzinga

Morning Brief: Top Stories Dominating Financial Media on Friday, April 1

Reuters IEA Holds Emergency Meeting To Tackle Soaring Oil Prices

Benzinga

Rosenblatt Analyst Explains How AMD Stock Weakness Is Buying Opportunity

Competitor downgrade on 2023 cyclical issues, potential consumer weakness in PCs and mobile, and a possible price war with Intel Corp (NASDAQ:INTC) drove Advanced Micro Devices Inc (NASDAQ:AMD) shares' weakness, Rosenblatt analyst Hans Mosesmann said. Barclays recently downgraded the rating on AMD, citing looming cyclical risks in 2023 across several end markets. However, Mosesmann contends that AMD is…

1 … 802 803 804 805

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.